Background In systemic lupus eryth-
Methods Twenty seven 27 patients with systemic lupus erythematosus were studied, ten of whom were consecutive untreated patients and 17 having clinically active disease and being treated. They were prospectively evaluated on the basis of erythrocyte sedimentation rate, lymphocyte count, C3 degradation products, quadriceps muscle biopsy, spirometry, lung volumes, carbon monoxide transfer factor, and mouth pressure during a maximal sniff. Results Lung function test results were abnormal in 12 patients. Vital capacity was reduced in seven, carbon monoxide transfer factor capacity in five, and mouth pressure was low (< 70% predicted) in ten. Lymphocytic (26) 91 (23) 101 (14) 90 (24) 
Correlations were determined by the Pearson product moment correlation coefficient, significance levels being taken from standard tables.26 Unpaired student's t tests were used to investigate the relationship of lung function with the presence of antibodies to Ro and La, lymphocytic vasculitis, and abnormal results in laboratory tests.
The study was approved by the University Hospital ethical committee.
Results
Comparisons of lung function in patients with normal and abnormal laboratory test results are presented in the table. Erythrocyte sedimentation rate was raised (> 20 mm in one hour) in 17 patients, and C3dg was elevated (over 15 units/ ml) in eight patients. Lymphopenia (< 1-5 x 109 cells/ml) was seen in 20 patients. Six patients had antibodies to Ro and La, four to Ro alone, and 13 to neither, of whom five were RNP positive and two had unidentified extractable nuclear antigens.
The histological appearance of muscle biopsy specimens showed evidence of lymphocytic vasculitis in ten patients, two of whom had an elevated creatine kinase (CK). Type II fibre atrophy was coexistent with lymphocytic vasculitis, and was present in isolation in three patients.
Lung function values of <80% predicted were taken as abnormal, except for TLco and Pmo, where <70% was considered abnormal. Lung function results were abnormal in 12 of the 27 patients (44%); percentage predicted FVC was reduced in seven patients, TLCO in five, FEV1/FVC ratio (below 70%/.) in two, and Pmo in ten. Of the ten untreated patients, lung function was abnormal in two, both having a reduced TLCO, and Pmo was low in four. The percentage predicted TLC was significantly lower in the treated patients than in the untreated group (p < 0 02). 
